Granules India has reported results for its third quarter ended December 31, 2011.
The company’s net profit declined by 4.94%, to Rs 5.96 crore in the third quarter ended December 31, 2011 compared with Rs 6.27 crore in the year-ago period. Net sales grew 41.20% to Rs 155.56 crore in the quarter under review as compared with Rs 110.17 crore in the same quarter last year.
The company’s consolidated net profit increased 41.92%, to Rs 7.99 crore in the third quarter ended December 31, 2011 compared with Rs 5.63 crore in the year-ago period. Net sales grew 45% to Rs 185.72 crore in the quarter under review as compared with Rs 128 crore in the same quarter last year.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: